User profiles for Eric Weh
Eric WehResearch Investigator, University of Michigan Verified email at med.umich.edu Cited by 602 |
[HTML][HTML] Race-and sex-related differences in retinal thickness and foveal pit morphology
Purpose.: To examine sex-and race-associated differences in macular thickness and foveal
pit morphology by using spectral-domain optical coherence tomography (SD-OCT). Methods.…
pit morphology by using spectral-domain optical coherence tomography (SD-OCT). Methods.…
8q21. 11 microdeletion in two patients with syndromic peters anomaly
H Happ, KF Schilter, E Weh, LM Reis… - American Journal of …, 2016 - Wiley Online Library
Peters anomaly is a form of anterior segment dysgenesis characterized by central ocular
opacity and corneo‐lenticular adhesions. Isolated and syndromic Peters anomaly can be …
opacity and corneo‐lenticular adhesions. Isolated and syndromic Peters anomaly can be …
Whole exome sequence analysis of Peters anomaly
E Weh, LM Reis, HC Happ, AV Levin, PG Wheeler… - Human genetics, 2014 - Springer
Peters anomaly is a rare form of anterior segment ocular dysgenesis, which can also be
associated with additional systemic defects. At this time, the majority of cases of Peters anomaly …
associated with additional systemic defects. At this time, the majority of cases of Peters anomaly …
Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes
Peters plus syndrome ( PPS ) is a rare autosomal‐recessive disorder characterized by
Peters anomaly of the eye, short stature, brachydactyly, dysmorphic facial features, …
Peters anomaly of the eye, short stature, brachydactyly, dysmorphic facial features, …
Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma
ME Protas, E Weh, T Footz, J Kasberger… - Human Molecular …, 2017 - academic.oup.com
Mutations in FOXC1 and PITX2 constitute the most common causes of ocular anterior segment
dysgenesis (ASD), and confer a high risk for secondary glaucoma. The genetic causes …
dysgenesis (ASD), and confer a high risk for secondary glaucoma. The genetic causes …
[HTML][HTML] Hexokinase 2 is dispensable for photoreceptor development but is required for survival during aging and outer retinal stress
Photoreceptor death is the ultimate cause of vision loss in many retinal degenerative conditions.
Identifying novel therapeutic avenues for prolonging photoreceptor health and function …
Identifying novel therapeutic avenues for prolonging photoreceptor health and function …
Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration
Synthetic high-density lipoprotein (sHDL) and rapamycin (Rap) have both been shown to
be potential treatments for age-related macular degeneration (AMD). The low aqueous …
be potential treatments for age-related macular degeneration (AMD). The low aqueous …
[HTML][HTML] Metabolic Alterations Caused by Simultaneous Loss of HK2 and PKM2 Leads to Photoreceptor Dysfunction and Degeneration
E Weh, M Goswami, S Chaudhury, R Fernando… - Cells, 2023 - mdpi.com
HK2 and PKM2 are two main regulators of aerobic glycolysis. Photoreceptors (PRs) use
aerobic glycolysis to produce the biomass necessary for the daily renewal of their outer …
aerobic glycolysis to produce the biomass necessary for the daily renewal of their outer …
[HTML][HTML] Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis
Photoreceptor cell death is the ultimate cause of vision loss in many retinal disorders, and
there is an unmet need for neuroprotective modalities to improve photoreceptor survival. …
there is an unmet need for neuroprotective modalities to improve photoreceptor survival. …
[HTML][HTML] Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor Apoptosis
…, S Chaudhury, BT Watch, JA Stuckey, E Weh… - Pharmaceuticals, 2023 - mdpi.com
Treatment options are lacking to prevent photoreceptor death and subsequent vision loss.
Previously, we demonstrated that reprogramming metabolism via the pharmacologic …
Previously, we demonstrated that reprogramming metabolism via the pharmacologic …